The novel coronavirus is putting pharma’s complicated global supply chain under strain, no question. What’s up in the air is just how supplies could be affected––and unfortunately, analysts just can’t be sure. Why? Lack of transparency, for one thing. A dearth of information is making it hard on pharma watchers who’d like to diagnose the growing… Read More »
Digital health tools are shifting the paradigm for companies developing new therapeutics or medical devices, from early-stage innovation through the entire lifecycle of a product – with potential to make innovation more efficient, extend business lines and enhance provider and patient relationships. Bob Coughlin, president and CEO of Mass Biotech Council, will be speaking on… Read More »
The chairman of Purdue Pharma’s board told CNBC on Monday that the OxyContin maker’s bankruptcy and tentative deal to resolve massive opioid lawsuits were the “only way” to get help to victims of the crisis as quickly as possible. “We’re turning [the company] into a public trust organization,” Steve Miller said in an interview with… Read More »
NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said. FILE PHOTO:… Read More »
(Reuters) – OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $ 10 billion to $ 12 billion, two people familiar with the matter said on Tuesday. Purdue is among several drugmakers and distributors that have been sued for… Read More »